Biotechnology research and products from Berlin, since 1992.
Biotechnologische Forschung und Produkte aus Berlin, seit 1992.
Acquired by BBI Solutions Jan 2022
As the end of the year is near we would like to take the opportunity to thank all our customers worldwide for their continuous loyalty.
We wish you a peaceful holiday season and look forward to seeing you again in 2023.
2023 Pricing Notification
We have released a notice of price changes that are effective immediately for all orders that will be shipped on or after 1st January 2023. For more details and background please follow the link below
https://t.co/QawDswdz2V
Large lot sizes are important factors to consider for assay manufactures to minimize costly pre-tests. BBI offers scalable production models to fit your assay needs. To learn more schedule a meeting with us at WRIB 2022 in Atlanta by using the link below:
https://t.co/0F1rVO5uKg
Meet us at WRIB 2022 booth 54 to learn more about our antibodies against a wide range of targets, even those that differ by only a few amino acids such as anti-idiotypic antibodies. To schedule a meeting with us at WRIB, please click:
https://t.co/DliX76McsC
#antibodyservices
The 16th WRIB conference in Atlanta, GA is getting closer, and BBI solutions will be there showcasing our range of MBS products! Will you be attending this year? If so, do not delay in booking a meeting with the MBS team on-site: https://t.co/DrrvMA5aUQ
It is your last chance to meet the BBI Solutions team at #AACC2022 at booth #853. Come on over to learn about
- Our new Anti-CRP and Anti-IgE antibodies
- Our new range of molecular tag gold conjugates
- Our wide range of diagnostic enzymes
#AACC2022#IVD#POCT
After a successful 1st day at #AACC2022, our team are looking forward to another busy day. Why not visit us at booth #853 to learn more about our new Anti-CRP and Anti-IgE antibodies or our Molecular tag Gold Conjugate range.
We are all setup for #AACC2022 and are looking forward to meeting our existing customers and new prospective customers over the few days.
Visit booth 853 to learn how BBI's Polystreptavidin could improve your assay sensitivity.
#AACC#IVD#POCT#LateralFlow
We are all setup for #AACC2022 and are looking forward to meeting our existing customers and new prospective customers over the few days.
Visit booth 853 to learn how BBI's Polystreptavidin could improve your assay sensitivity.
#AACC#IVD#POCT#LateralFlow
Meet us at AACC 2022 at booth #853 to talk to our technical experts and discuss how BBI Solution’s anti-CRP antibody can be used in your assay.
Schedule a meeting with our team today: https://t.co/etyROU2OSp
#AACC#inflammation
AACC 2022 | Meet our team in Chicago at booth # 853 and discover what is new.
Please click here to find out why using Polystreptavidin R in your Lateral Flow Assay can make a difference: https://t.co/Z61eSB8GQa
Recent studies reported a very high prevalence of thrombosis in COVID-19 patients. Is the mechanism leading to thrombosis in these patients related to what is seen in patients with Antiphospholipid Syndrome? Read our blogpost discussing this topic here: https://t.co/cIvva6OsJx
We are looking for feedback on your experience working with BBI
For every survey completed we will donate £10 to UNICEF's children's charity campaign " For every child in danger"
Click the link below to complete the survey
https://t.co/xypsqO0Lck
Our team are visiting the 13th International Congress on Autoimmunity. Contact us (https://t.co/BhhhHjLxro to setup a meeting to learn more about our complete range of autoimmune antigens, humanized antibodies and SBA Autoimmune ELISA range. #ELISA#autoimmune#greece
To discover more, please visit our website to download your copy of the autoimmune diabetes brochure. https://t.co/4wTM22AAOV
To discover more about our other Diabetes related products please visit:
https://t.co/dDZsaYLcSg
https://t.co/bxrkAdS5Pb
The World Thyroid Day was established in 2008 to increase awareness of thyroid diseases.
Visit our website to find out more about our thyroid disease immunoassay reagents: https://t.co/aI5tAVeCx6
Diagnostic ELISAs from SBA: https://t.co/y47chAygoI